Glucidion G 10

Glucidion G 10 is an intravenous solution for injection that combines glucose anhydrous, potassium chloride, and sodium chloride in a single formulation. It is supplied as a sterile liquid preparation intended for fluid and electrolyte replenishment in clinical settings. The product is marketed in the European Union and requires a prescription. Its composition provides both an energy source and essential electrolytes for patients needing parenteral support.

Glucidion G 10 is indicated for clinical situations where rapid restoration of blood glucose and electrolyte balance is required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Fluid and electrolyte replacement during surgery or trauma. - Support of parenteral nutrition regimens that need carbohydrate and electrolyte provision. - Management of potassium or sodium deficits in hospitalized patients. - Adjunct therapy in patients receiving intravenous medications that may cause electrolyte shifts. - Rehydration in patients with dehydration combined with low blood glucose. - Use in perioperative care to maintain intraoperative glucose and electrolyte homeostasis.

The safety profile of Glucidion G 10 reflects the typical reactions associated with intravenous glucose and electrolyte solutions. Most adverse events are mild, transient, and resolve without specific treatment, while serious complications are uncommon but require prompt medical attention.

Clinicians should monitor patients for these effects during and after infusion to ensure safety.

Individual susceptibility varies, and the incidence of reactions may be influenced by infusion rate and underlying health conditions.

Common: - Mild irritation at the injection site. - Transient increase in blood glucose levels. - Slight nausea or vomiting. - Temporary electrolyte imbalance that resolves with monitoring. - Mild headache or dizziness during infusion.

Serious: - Hyperkalemia leading to cardiac arrhythmias. - Severe hypernatremia causing neurological symptoms.

Precautions for using Glucidion G 10 focus on patient assessment, monitoring, and appropriate administration techniques to minimize risks.

Healthcare providers should evaluate electrolyte status, renal function, and glucose levels before initiating therapy.

- Verify serum potassium and sodium concentrations to avoid overcorrection. - Assess renal function, as impaired kidneys may reduce clearance of electrolytes. - Monitor blood glucose closely, especially in diabetic or hypoglycemic patients. - Adjust infusion rate in patients at risk of fluid overload or cardiac compromise. - Avoid rapid bolus administration unless specifically indicated. - Document any adverse reactions and report serious events per institutional policy.

Glucidion G 10 may interact with other intravenous therapies or medications that affect electrolyte balance, glucose metabolism, or renal function.

Awareness of these potential interactions helps clinicians plan safe concurrent treatments.

Avoid: - Concurrent use with high‑dose potassium supplements, which may cause hyperkalemia. - Simultaneous infusion of hypertonic saline solutions, increasing risk of hypernatremia.

Use with caution: - Co‑administration with insulin or oral hypoglycemics; glucose load may require dose adjustment. - Use with diuretics that alter potassium or sodium excretion; electrolyte monitoring is essential. - Administration alongside nephrotoxic drugs; impaired renal clearance can affect electrolyte levels. - Concurrent infusion with calcium-containing solutions; monitor for precipitation and calcium‑potassium interactions.